Correlation Between UBS Plc and Surgical Science

Can any of the company-specific risk be diversified away by investing in both UBS Plc and Surgical Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UBS Plc and Surgical Science into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UBS plc and Surgical Science Sweden, you can compare the effects of market volatilities on UBS Plc and Surgical Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UBS Plc with a short position of Surgical Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of UBS Plc and Surgical Science.

Diversification Opportunities for UBS Plc and Surgical Science

0.78

Correlation Coefficient

UBS Plc  Surgical Science

Poor diversification

The 3 months correlation between UBS and Surgical is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding UBS plc and Surgical Science Sweden in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surgical Science Sweden and UBS Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UBS plc are associated (or correlated) with Surgical Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surgical Science Sweden has no effect on the direction of UBS Plc i.e., UBS Plc and Surgical Science go up and down completely randomly.

Pair Corralation between UBS Plc and Surgical Science

Assuming the 90 days trading horizon UBS plc is expected to generate 0.26 times more return on investment than Surgical Science. However, UBS plc is 3.9 times less risky than Surgical Science. It trades about 0.14 of its potential returns per unit of risk. Surgical Science Sweden is currently generating about 0.03 per unit of risk. If you would invest  816,384  in UBS plc on September 9, 2024 and sell it today you would earn a total of  104,016  from holding UBS plc or generate 12.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.23%
Values	Daily Returns

UBS plc   vs.  Surgical Science Sweden

UBS plc

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in UBS plc are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, UBS Plc may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Surgical Science Sweden

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Surgical Science Sweden are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Surgical Science unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with UBS Plc and Surgical Science

The main advantage of trading using opposite UBS Plc and Surgical Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UBS Plc position performs unexpectedly, Surgical Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surgical Science will offset losses from the drop in Surgical Science's long position.

The idea behind UBS plc and Surgical Science Sweden pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.